Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome

Stopped early · Not applicable

Conditions studied: Hepatorenal Syndrome, Renal Failure, Liver Diseases

In brief

This Study will look at the effect of substances called "angiogenic factors"(development of new blood vessels) have on the development of severe liver disease. The results may help to understand the factors involved in the repair and regeneration of liver tissue and to see if different types of liver disease are associated with different types of factors, especially in the severe liver disease called hepatorenal syndrome.

Key facts

Study ID

NCT00734136

Run by

Lahey Clinic

People needed

100

Starts

2005-05-01

Expected to finish

2009-02-01

Last updated by the study team

2009-02-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Sign informed consent
• Subjects who present for Liver Transplantation
• Subjects who present for Hepatic resection
• Subjects with Non-Surgical Liver Disease

You may not qualify if…

• Absence of Liver Disease

Where it is running

• Lahey Clinic, Inc. — Burlington, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.